Design and validation of a questionnaire to measure the knowledge and performance of dentists regarding dental considerations in patients receiving bisphosphonate
Year: 2026
Type: article
Abstract: BACKGROUND: Performing invasive dental treatments during the period of taking bisphosphonates can lead to a complication called medication-related osteonecrosis of the jaw (MRONJ). The aim of this study was to design and validate a questionnaire to measure the knowledge and performance of dentists regarding the dental considerations of patients using bisphosphonates. METHODS: In this study, after designing the initial questionnaire, the content validity was assessed by 15 dental using content validity index (CVI) and ratio (CVR). Validity and reliability of the scale were examined by using confirmatory factor analysis, the Cronbach alpha, composite reliability (CR), and the average variance extracted (AVE) tests. RESULTS: "In this cross-sectional descriptive study, after reviewing articles, guidelines, and reference books, a questionnaire was designed to measure dentists' knowledge and performance regarding dental considerations for patients receiving bisphosphonates. After confirming face and content validity, Exploratory Factor Analysis (EFA) was conducted to investigate the underlying dimensional structure, suggesting a two-component (comprising awareness and performance) explaining 66.57% and 89.76% of variance, respectively. This structure was confirmed by Confirmatory Factor Analysis (CFA). The scale also demonstrated appropriate reliability (α = 0.909 and 0.848) and composite reliability (CR > 0.7). CONCLUSION: The study provided a brief, valid, and reliable measure to assess dentists' awareness of dental considerations in patients receiving bisphosphonates, the risk of MRONJ complications, and dental procedures related to MRONJ complications, as well as questions related to measuring performance and clinical decision-making by dentists.
Source: BDJ Open
Language: English
Topic: Bone health and treatments
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $3,590
OpenAlex ID: W7236773317
